Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Echelon Biosciences Incorporated

Echelon Biosciences was formed from a project under the Center for Cell Signaling, a State of Utah Center of Excellence, and was incorporated under the laws of the state of Utah as Echelon Research Laboratories, Inc. on October 3, 1997. The company has since changed its name to Echelon Biosciences Incorporated. The company was organized to further the science of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease


Contact Details:
675 Arapeen Drive, Suite 302
Salt Lake City
Utah
84108
United States of America
Tel:801-588-0455
Fax:801-588-0497
Email:echelon@echelon-inc.com
WWW:

www.echelon-inc.com/




Loading...

Recent Publications by Echelon Biosciences Incorporated:

Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity.
[reaction: see text] Lysophospholipase D (lysoPLD), also known as...
16th February, 2007
Echelon Biosciences Inc., Salt Lake City, Utah 84108, USA. Org Lett. 2006 May 11;8(10):2023-6.
DOI Direct Link
Phosphoinositide-containing polymerized liposomes: stable membrane-mimetic vesicles for protein-lipid binding analysis.
Stable phosphoinositide (PIP(n))-containing liposomes were prepared using...
24th January, 2006
Echelon Biosciences Inc., 675 Arapeen Drive, Suite 302, Salt Lake City, Bioconjug Chem. 2005 Nov-Dec;16(6):1475-83.
DOI Direct Link
Probing lipid-protein interactions using lipid microarrays.
Lipids are central to the regulation and control of several cellular...
16th December, 2005
Echelon Biosciences Inc., 675 Arapeen Way, Suite 302, Salt Lake City, UT Prostaglandins Other Lipid Mediat. 2005 Sep;77(1-4):158-67.
DOI Direct Link
Visualizing signalling by phosphoinositide 3-kinase pathway lipids.
Cells signal through lipids produced by phospholipid and phosphoinositide...
23rd December, 2004
Department of Medicinal Chemistry, University of Utah, and Echelon Biochem Soc Trans. 2004 Apr;32(Pt 2):336-7.
DOI Direct Link
The methylerythritol phosphate pathway and its significance as a novel drug target.
Isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) are...
8th April, 2004
Echelon Biosciences, Curr Pharm Biotechnol. 2003 Aug;4(4):248-59.

View more Echelon Biosciences Incorporated research publications.

Echelon Biosciences Incorporated Patents:

US Patent No.Title
7459285 Compounds and methods of use thereof for assaying lysophospholipase D activity
7067269 Assaying apparatus, kit, and method for lipids and associated enzymes

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 312 times since April 2007, the link to the organisation's website has been followed 52 times

Recent Search Terms used to find this page: echelon biosciences | echelon biosciences | echelon biosciences | echelon bioscience | echelon bioscience | Echelon biosciences | .

Search for more companies in Salt Lake City

Search for more companies in Utah



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Echelon Biosciences Incorporated

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.